Sign in

CIK 0001422143 · Non-accelerated filer<br>Smaller reporting company

Kura Oncology, Inc.

Sign in to watch
Ticker
KURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
611547851
Phone
(858) 500-8800
Business address
4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
Former names
ZETA ACQUISITION CORP III
  1. 8-K Event Material agreement
  2. 4 Derivatives Options or other derivatives
  3. 3 Insider Initial Statement of Ownership
  4. 10-Q Report Quarterly Report
  5. 8-K Event Results of operations
  6. 4 Open-market buy Director bought 50,000 shares at $11.50 ($575,000)
  7. 8-K Event Other events
  8. 424B5 Offering Prospectus
  9. 424B5 Offering Prospectus
  10. 8-K Event Other events
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. S-8 Other Securities Offered to Employees in Benefit Plans
  19. 8-K Event Executive or director change · Shareholder vote results
  20. 10-Q Report Quarterly Report

Page 14 of 41 · 809 filings